Fig. 8

RS-based analysis of ICB immunotherapy response. A Result of ICB immunotherapy response prediction in TCGA-STAD patients. B–D Differences in ICB immunotherapy response, EaSIeR immune score and TIDE score between the low-risk and high-risk groups. E–H Influence of immune cells, cell communication, transcription factors and ligand receptor pairs on ICB treatment response